Abstract

A novel SIK2 inhibitor SIC-19 is synthetic lethal with PARP inhibitors in ovarian cancer (2298)

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
PARP inhibitor and chemotherapy combination trials for the treatment of advanced malignancies: does a development pathway forward exist?
B.J Monk ... U.A Matulonis
Annals of Oncology | VOL. 28
B.J Monk, et. al.B.J Monk ... U.A Matulonis
01 Mar 2017
Abstract 626: Bromodomain inhibition in ovarian cancer and the tumor microenvironment to improve PARP inhibitor response
Esther Liu ... Andrew J Wilson
Cancer Research | VOL. 78
Esther Liu, et. al.Esther Liu ... Andrew J Wilson
01 Jul 2018
Abstract 7135: Preclinical effects of Tumor Treating Fields (TTFields) with PARP inhibitors in ovarian cancer
Roni Monin ... Uri Weinberg
Cancer Research | VOL. 84
Roni Monin, et. al.Roni Monin ... Uri Weinberg
22 Mar 2024
Prior authorizations for PARP inhibitors in ovarian cancer.
Ashley Ford Haggerty ... Daniella Pena
Journal of Clinical Oncology | VOL. 40
Ashley Ford Haggerty, et. al.Ashley Ford Haggerty ... Daniella Pena
01 Jun 2022
View more papers

More From: Gynecologic Oncology

Paper Title
Journal
Date
Author
Determination of quality of life-related health utilities for surgical complications in ovarian cancer
Larissa A Meyer ... Rudy S Suidan
Gynecologic Oncology | VOL. 185
Larissa A Meyer, et. al.Larissa A Meyer ... Rudy S Suidan
01 Jun 2024
The impact of Black founding fathers on the specialty of gynecologic oncology
Cyril O Spann ... Dineo Khabele
Gynecologic Oncology | VOL. 185
Cyril O Spann, et. al.Cyril O Spann ... Dineo Khabele
01 Jun 2024
Implementation of a surgical site infection prevention bundle in gynecologic oncology patients: An enhanced recovery after surgery initiative
Anna Cameron ... Shannon M Ruzycki
Gynecologic Oncology | VOL. 185
Anna Cameron, et. al.Anna Cameron ... Shannon M Ruzycki
01 Jun 2024
DEAR model in overweight endometrial cancer patients undergoing fertility-sparing treatment: A randomized controlled trial
Jingjing Gong ... Lianhua Bai
Gynecologic Oncology | VOL. 185
Jingjing Gong, et. al.Jingjing Gong ... Lianhua Bai
01 Jun 2024
View more papers